Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+4.82M
-
Total reported value, excl. options
-
$363M
-
Value change
-
+$58.6M
-
Put/Call ratio
-
0.31
-
Number of buys
-
63
-
Number of sells
-
-42
-
Price
-
$11.31
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q3 2021
150 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q3 2021.
Altimmune, Inc. - Common Stock (ALT) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 80.7M outstanding shares and own 39.74% of the company stock.
Largest 10 shareholders include VR Adviser, LLC (3.8M shares), STATE STREET CORP (3.52M shares), BlackRock Inc. (2.94M shares), Avidity Partners Management LP (2.17M shares), VANGUARD GROUP INC (1.64M shares), TANG CAPITAL MANAGEMENT LLC (1.6M shares), CREDIT SUISSE AG/ (1.41M shares), CITADEL ADVISORS LLC (1.09M shares), SPHERA FUNDS MANAGEMENT LTD. (1.09M shares), and BAKER BROS. ADVISORS LP (1.07M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.